Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cells-Reference-Cited by-同舟云学术

Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cells

Published:1988-07-15 Issue:1 Volume:42 Page:42-47
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Berends D.,Mulder A. H.,van Houwelingen G.,de Both N. J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

2. Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.

3. , , , , , and , The detection of virally induced tumors by 131I- and 125I-labelled syngeneic monoclonal antibodies. Cancer Immunol. Immunother. (1988b) (In press).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth;Clinical and Experimental Immunology;1995-12

2. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;1992-02

3. Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodies;International Journal of Cancer;1991-01-02

4. Spontaneously Metastasizing Variants of a Human Lung Carcinoma Cell Line: Monoclonal Antibody Characterization;Tumor Biology;1990

5. Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumour cell lines;British Journal of Cancer;1989-09